Furthermore, the present study demonstrated that FAK siRNA and RhoA siRNA attenuated the expression of membrane-bound RhoA and malignant cellular behavior in non-metastatic RCC cells without changing the expression of EphA2 protein and of EphA2 protein/phosphorylated FAK, respectively. Here, PTK2 is linked to renal cell carcinoma.